Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | +4.53% | +2.04% | -22.68% |
Business Summary
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 16-10-31 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 21-09-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 99-06-30 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 19-10-22 |
Arnold Baskies
BRD | Director/Board Member | 74 | 16-07-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,899,800 | 30,334,712 ( 95.09 %) | 0 | 95.09 % |
Company contact information
Anixa Biosciences, Inc.
3150 Almaden Expressway Suite 250
95118, San Jose
+408 708 9808
http://www.anixa.comSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.68% | 95.7M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ANIX Stock
- Company Anixa Biosciences, Inc.